Jason Park, PhD is CEO and co-founder of Empress. He is also an Operating Partner at Flagship Pioneering and was a member of the founding team of Sonata Therapeutics where he served as COO.
Prior to joining Flagship in 2015, Jason was a core member of the Boston Consulting Group’s Health Care and Technology practices, operating out of BCG's New York, Mumbai, and Paris offices. His projects included multiple large life science M&A opportunities and the design and implementation of a new funding model for a multinational Global Health organization focused on innovative technologies and interventions. Previously, Jason was a director at an early-stage biotech start-up focused on targeted drug delivery as well as the co-founder of an internet advertising firm.
Jason earned a Ph.D., M.S., and B.S. in Biomedical Engineering from Yale University where his research focused on the use of nanotechnology for immunomodulatory purposes and culminated in the invention and clinical use of a nanoparticle drug delivery platform. He is the author of multiple patents, book chapters, and over a dozen peer-reviewed papers in journals including Nature and Cell.